Dapagliflozin ((2S) -1,2-propanediol, hydrate) - CAS 960404-48-2

Dapagliflozin ((2S) -1,2-propanediol, hydrate) (BMS-512148 (2S) -1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2), in development for treating type 2 diabetes mellitus (T2DM) . It inhibits SGLT2, responsible for at least 90% of glucose reabsorption in the kidney.

SGLT

GPCR/G Protein

960354

0.9994

C24H35ClO9

502.98

O.O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c3ccc(Cl)c(Cc2ccc(OCC)cc2)c3.C[C@H](O)CO

-20°C

Ice Packs

Small Compound